Treatment of SARS Caused by COVID-19 With Ruxolitinib

Clinical trial NCT04334044 · COMPLETED

Trial details

NCT number: NCT04334044
Sponsor: Grupo Cooperativo de Hemopatías Malignas
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2

Start date: 2020-09-01
Primary completion: 2021-04-12
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.